Reminder: OOS Survey - Participation possible until 8 April
Recommendation

Thursday, 3 December 2026 9 .00 - 17.00 h
Streamlining and Smart Design of Processes
As reported in our last newsletter, the ECA Analytical Quality Control Group (AQCG) is currently collecting input via a short survey to support the revision and update of its guidance on Out-of-Specification (OOS) investigations.
If you have not yet participated, participation is still possible until 8 April 2026.
All responses will be evaluated in an aggregated and fully anonymized manner. None of the questions are mandatory, and participants may skip any questions they prefer not to answer. At the end of the survey, respondents are also invited to propose additional topics or questions that AQCG should consider in future guidance documents.
The revision of the guideline is planned immediately after the survey closes, and a summary report of the survey results will be prepared and made available to all members.
Thank you for your valuable time and support.
Related GMP News
02.11.2026FDA Warning Letter: When Test Procedures Allow Retesting Until an Acceptable Result is Obtained
21.10.2026EMA Updates Information Page on Bioequivalence Guidelines
21.10.2026BP Publishes new Draft Texts
21.10.2026FDA Identifies Critical Deficiencies in Analytical Testing and CGMP Oversight
07.10.2026Analytical Quality Group Developments May through August 2026
07.10.2026Two New FDA Warning Letters Put OOS Investigations in Focus


